|
|
|
|
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystro
Muscular Dystrophy / ALS News Main Category: Muscular Dystrophy / ALS email to a friend printer friendly view / write opinions Current Article Ratings: Patient / Public: 4.33 (3 votes) Health Professional: 5 (1 votes) Article Opinions: AVI BioPharma, Inc....
|
|
|
Drug Prices Versus Drug Costs: Getting It Right To Show Value
Setting drug prices by the manufacturer and estimating the true drug costs by the purchaser are important issues for decision-makers, manufacturers, and patients when assessing the value of a drug therapy.In January, the International...
|
|
|
IntelGenx Receives FDA Complete Response Letter CPI-300
IntelGenx announced receipt of a Complete Response Letter from the U.S.Food and Drug Administration ("FDA") regarding the Company's New Drug Application ("NDA") for its antidepressant CPI-300, which it developed with Cary Pharmaceuticals (...
|
|
|
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Dublin - Research and Markets (http://www.researchandmarkets.com/research/7fd315/drug-delivery-in-c) has announced the addition of Jain PharmaBiotech's new report ' ' to their offering.The delivery of drugs to central nervous system (CNS) is a...
|
|
|
Research and Markets: The World Market Report on Biomarkers, Tests and Trends for Drug R
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2829b0/biomarkers_tests) has announced the addition of the "Biomarkers, Tests and Trends for Drug R&D" report to their offering.This report is about the world...
|
|
|
Research and Markets: Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016
Research and Markets ( www.researchandmarkets.com/research/cea70d/chronic_obstructiv : ) has announced the addition of GlobalData 's new report " Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016 : " to...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Feb 9, 2010 - ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA s Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.-- (BUSINESS WIRE) -- (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX: CXS.AX) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee ...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
(BUSINESS WIRE) ----ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February ..
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Schedu
MELBOURNE, Australia & MENLO PARK, Calif.--(EON: Enhanced Online News)--ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee
BusinessWire - ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAEURs Oncologic Drugs Advisory Committee Meeting Sche
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)-- ChemGenex Pharmaceuticals Limited (ASX: CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee ...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS - News) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS - News) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); MELBOURNE, Australia & MENLO PARK, Calif.- (Business Wire) ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food and Drug Administration (FDA) has notified the...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 F
ebruary 2010 MELBOURNE, Australia & MENLO PARK, Calif.- (BUSINESS WIRE) - ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
